 Dr.Shruti Bhat, Leader Pharmaceutical R&D and Expert in hiTech formulation development for over 35 different therapeutic class of drugs moeities, brings to you some highlights from current pharma and clinical research news, views and data. Presented below are updates in Pharmaceutical and clinical research- Pioglitazone May Slow, Stop Progression Of Insulin Resistance To Full-Blown Diabetes. According to research presented at the World Congress on Controversies to Consensus in Diabetes, Obesity, and Hypertension, "in patients with insulin resistance but near-normal glycated hemoglobin levels... Biosimilar Development Said To Be More Difficult Than Generic Endeavors. Merck & Co.'s decision to end its effort to copy Amgen Inc.'s Aranesp (darbepoetin alfa) anemia drug may highlight the difficulties drugmakers face when developing biosimilars. The FDA is ... Biotech Industry Sees Profitable Year Following Research Cuts. Bloomberg News reported "Biotechnology companies worldwide turned a profit last year for the first time since at least 1985 as those led by Celgene Corp. reduced ... Gates Invests In Drug-Software Company To Aid Drug Development. The Wall Street Journal reported Microsoft Corp. co-founder Bill Gates is investing $10 million in Schrodinger LLC, a pharmaceutical-software maker, as part of a bid to improve drug development. The investment will put Gates ... Remission In RA Possible With Biologic Drugs. MedPage Today reported that "more than half of rheumatoid arthritis patients who achieved remission during treatment with infliximab (Remicade) were able to discontinue the drug for more than a year without flaring," according to a study published online ... Methadone Use During Pregnancy Associated With Risk Of Visual Problems In Babies. MedPage Today reported that, according to a study published online in the British Journal of Ophthalmology, "infants whose ... Liraglutide Added To Metformin May Benefit Patients With Type 2 Diabetes. HealthDay reported that, according to a study published April 24 in The Lancet, "patients with type 2 diabetes who can't control their blood glucose levels with the drug metformin alone do better after adding injections of the drug liraglutide compared to oral doses of another drug called ... FDA Tightening Its Oversight Of Infusion Pumps. Food and Drug Administration officials are "moving to tighten their oversight of medical devices, including one of the most ubiquitous and problematic pieces of medical equipment," the infusion pump. Approximately ... More at ...http://www.pharm-education.com/2010/05/biosimilar-development-said-to-be-more.html Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances. Http://www.drshrutibhat.com Expert at leading Pharmaceutical R&D. Translates innovative concepts to PROFITS. YouTube Channel : Http://www.youtube.com/user/ShrutiBhat10 Do you have questions for the author? CommentsLeave a Reply | The pharmaceutical business is yet another dynamic venture, present globally and extremely important to research scientists, investors and the entire community at large.  ArchivesAugust 2010 Categories |
RSS Feed